Not Like EKG But maybe like BLRX.
EKG is in the medical devices field and the market is excited over FDA approval of its heart monitor.
BLRX doubled today (increased market cap by 45MM) on a licensing deal with a french pharma. The similarity to GAP is they have just proved the safety of a pill that may be useful in treating Hep C. They haven't started Clinical studies. That puts them in the same time frame as PharmaGap (I think).
I licensing deal that increases our market cap by 45MM would be welcomed.
Alan